Weather Blocks Hunt For Refugee’s Ship

Mon., June 17, 1996

Compiled From Wire Services

A ship carrying hundreds of Liberian refugees was missing and possibly in distress Sunday off the West African coast, but bad weather blocked search efforts.

A five-hour aerial search off Ivory Coast and Ghana on Saturday failed to turn up the Russian freighter Zolotitsa, which has been at sea three weeks.

Local journalism is essential.

Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are tax deductible.

Meet Our Journalists

Jesse Tinsley

Meet Jesse Tinsley. As a certified drone pilot, this veteran Spokesman-Review photographer often can be seen capturing beautiful aerial photographs of our region. Sometimes though, the job requires getting down with the dogs.
Jim Meehan

Jim Meehan is no stranger to Zag Nation. As the lead writer covering the Gonzaga men’s basketball team, he tells the stories behind the game and gets fans a bit closer to their favorite players.
Molly Quinn

There is no artist in Spokane like Molly Quinn. Her whimsical style is instantly recognizable to readers of The Spokesman-Review. She has painted gorgeous illustrations that instantly elevate the journalism accompanying it. She brings to life the stories that defy photography. She makes our pages better.
Rob Curley

Spokesman-Review editor Rob Curley loves to talk with people and learn about their lives, whether it's a best-selling author or a stranger he meets downtown on his walk to lunch. It's that inquisitive nature combined with a playful sense of storytelling that helps make our newspaper different than most.

Weather Blocks Hunt For Refugee’s Ship

Jesse Tinsley

Jim Meehan

Molly Quinn

Rob Curley

Scott Pelley accuses CBS News boss of 'Murdering' '60 Minutes'

Russia finance officials tell Putin war spending is unaffordable

‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long